Literature DB >> 9797249

Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.

G A Pankuch1, M R Jacobs, P C Appelbaum.   

Abstract

Quinupristin-dalfopristin produced postantibiotic effects (PAEs) and postantibiotic sub-MIC effects of >2 h against 18 gram-positive cocci. Mean pneumococcal and staphylococcal PAEs were 2.8 and 4.7 h, respectively, with shorter PAEs for constitutively than inducibly macrolide-resistant staphylococci. Mean PAEs for vancomycin-susceptible and -resistant Enterococcus faecium were 8.5 and 2.6 h, respectively.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9797249      PMCID： PMC105989     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500.

Authors:  S D Etienne; G Montay; A Le Liboux; A Frydman; J J Garaud
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

2.  Post-antibiotic effect of the new streptogramin RP 59500.

Authors:  N X Chin; H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

3.  Post-antibiotic effects of RP 59500 with Staphylococcus aureus.

Authors:  A Nougayrede; N Berthaud; D H Bouanchaud
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

Review 4.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC.

Authors:  F J Boswell; J M Andrews; R Wise
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

6.  The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.

Authors:  M Bergeron; G Montay
Journal:  J Antimicrob Chemother       Date:  1997-05       Impact factor: 5.790

7.  Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.

Authors:  I Odenholt-Tornqvist
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

9.  In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.

Authors:  L A Collins; G J Malanoski; G M Eliopoulos; C B Wennersten; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  Kinetics of antimicrobial activity.

Authors:  B Vogelman; W A Craig
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406
View more
  10 in total

1.  In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin against Klebsiella pneumoniae in a Neutropenic Murine Lung Infection Model.

Authors:  Yu-Feng Zhou; Meng-Ting Tao; Wei Huo; Xiao-Ping Liao; Jian Sun; Ya-Hong Liu
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Quinupristin/dalfopristin: the first available macrolide-lincosamide-streptogramin antibiotic.

Authors:  C Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

Review 4.  Treatment options for vancomycin-resistant enterococcal infections.

Authors:  Peter K Linden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Pronounced postantibiotic effect of quinupristin-dalfopristin in static cultures of Staphylococcus aureus: an effect not seen with other antibiotics.

Authors:  E Pfeil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.

Authors:  Chunna Guo; Xiaoping Liao; Mingru Wang; Feng Wang; Chaoqun Yan; Xia Xiao; Jiang Sun; Yahong Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

7.  Quinupristin-Dalfopristin.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

8.  Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities.

Authors:  Jing Lu; Lynne Turnbull; Catherine M Burke; Michael Liu; Dee A Carter; Ralf C Schlothauer; Cynthia B Whitchurch; Elizabeth J Harry
Journal:  PeerJ       Date:  2014-03-25       Impact factor: 2.984

Review 9.  Molecular Mechanisms of Drug Resistance in Staphylococcus aureus.

Authors:  Beata Mlynarczyk-Bonikowska; Cezary Kowalewski; Aneta Krolak-Ulinska; Wojciech Marusza
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

Review 10.  Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.

Authors:  Charles W Stratton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.